2026 AI Trading Bots: How AiTradeBtc Automates Trading in the Stock and Forex Markets
GlobeNewswire
Today at 10:56am UTC
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
Today at 10:52am UTC
EMBRAER EARNINGS RELEASE 1Q26
PR Newswire
Today at 10:51am UTC
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
GlobeNewswire
Today at 10:50am UTC
RE/MAX HOLDINGS, INC. REPORTS FIRST QUARTER 2026 RESULTS
PR Newswire
Today at 10:50am UTC
TELUS Corporation - NOTICE OF CASH DIVIDEND
PR Newswire
Today at 10:50am UTC
TELUS Corporation - NOTICE OF CASH DIVIDEND
PR Newswire
Today at 10:50am UTC
TELUS Corporation - NOTICE OF CASH DIVIDEND
PR Newswire
Today at 10:50am UTC
TELUS Announces Retirement of Chief Financial Officer Doug French and Appointment of Successor Gopi Chande
PR Newswire
Today at 10:47am UTC
TELUS Announces Retirement of Chief Financial Officer Doug French and Appointment of Successor Gopi Chande
PR Newswire
Today at 10:47am UTC
TELUS Announces Retirement of Chief Financial Officer Doug French and Appointment of Successor Gopi Chande
PR Newswire
Today at 10:47am UTC
Pressure Vessels Market worth $73.24 billion by 2031 | MarketsandMarkets™
PR Newswire
Today at 10:46am UTC
Castellum Announces First Quarter 2026 Financial Results
GlobeNewswire
Today at 10:45am UTC
TELUS reports operational and financial results for first quarter 2026
PR Newswire
Today at 10:45am UTC
Brookfield Asset Management Announces Strong First Quarter Results
GlobeNewswire
Today at 10:45am UTC
TELUS reports operational and financial results for first quarter 2026
PR Newswire
Today at 10:45am UTC
Brookfield Business Corporation Reports Strong First Quarter 2026 Results
GlobeNewswire
Today at 10:45am UTC
TELUS reports operational and financial results for first quarter 2026
PR Newswire
Today at 10:45am UTC
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted...
PR Newswire
Today at 10:40am UTC
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire
Today at 10:31am UTC